Robin Michelet
Freie Universität Berlin
H-index: 12
Europe-Germany
Top articles of Robin Michelet
Bayesian framework for multi-source data integration-Application to human extrapolation from preclinical studies
Statistical Methods in Medical Research
2024/4
Robin Michelet
H-Index: 6
Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort
Clinical Pharmacology & Therapeutics
2024/3/18
Inhalation of an immunomodulatory adjuvant to treat drug-resistant bacterial pneumonia
Revue des Maladies Respiratoires
2024/3/1
C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework
Cancers
2023/11/15
Robin Michelet
H-Index: 6
Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data
Clinical Pharmacokinetics
2023/10
Robin Michelet
H-Index: 6
Barriers to global pharmacometrics: educational challenges and opportunities across the globe
2023/6
Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients
Pharmaceuticals
2023/3/21
Robin Michelet
H-Index: 6
Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach
Frontiers in Pharmacology
2023/1/12
Robin Michelet
H-Index: 6
Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans
Pharmaceutical Research
2022/12
Robin Michelet
H-Index: 6
Quantification of the time course of CYP3A inhibition, activation, and induction using a population pharmacokinetic model of microdosed midazolam continuous infusion
Clinical Pharmacokinetics
2022/11
Robin Michelet
H-Index: 6
Microdialysis of drug and drug metabolite: a comprehensive in vitro analysis for voriconazole and voriconazole N-oxide
Pharmaceutical Research
2022/11
Robin Michelet
H-Index: 6
Ulcerative colitis and acute severe ulcerative colitis patients are overlooked in infliximab population pharmacokinetic models: results from a comprehensive review
2022/9/30
Robin Michelet
H-Index: 6
The Impact of Low Cardiac Output on Propofol Pharmacokinetics across Age Groups—An Investigation Using Physiologically Based Pharmacokinetic Modelling
Pharmaceutics
2022/9/16
High-dosage fosfomycin results in adequate plasma and target-site exposure in morbidly obese and nonobese nonhyperfiltration patients
Antimicrobial Agents and Chemotherapy
2022/6/21
Evaluation of a meropenem and piperacillin monitoring program in intensive care unit patients calls for the regular assessment of empirical targets and easy-to-use dosing …
Antibiotics
2022/6/2
Franz Weber
H-Index: 8
Robin Michelet
H-Index: 6
Comparative plasma and interstitial tissue fluid pharmacokinetics of meropenem demonstrate the need for increasing dose and infusion duration in obese and non-obese patients
Clinical Pharmacokinetics
2022/5
Exploring dried blood spot cortisol concentrations as an alternative for monitoring pediatric adrenal insufficiency patients: A model-based analysis
Frontiers in Pharmacology
2022/3/17
Robin Michelet
H-Index: 6
Towards the elucidation of the pharmacokinetics of voriconazole: a quantitative characterization of its metabolism
Pharmaceutics
2022/2/22
Robin Michelet
H-Index: 6
A versatile high-performance LC-MS/MS assay for the quantification of voriconazole and its N-oxide metabolite in small sample volumes of multiple human matrices for biomedical …
Journal of Pharmaceutical and Biomedical Analysis
2022/2/20
Robin Michelet
H-Index: 6
Combination of pharmacokinetic and pathogen susceptibility information to optimize meropenem treatment of gram-negative infections in critically Ill patients
Antimicrobial Agents and Chemotherapy
2022/2/15
Robin Michelet
H-Index: 6